4th Quarter - Report

SL STRATEGIES, LLC for ALLIANCE FOR A STRONGER FDA

Firm
Client
Income
$45,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Fiscal Year 2026 Food and Drug Administration Appropriations

LobbyistCovered position, as disclosed
MARY MOODY JOHNSON U.S. Senate Committee on Health, Education, Labor and Pensions
SARA LOVE RAWLINGS U.S. Senate Committee on Appropriations
JORDAN TENENBAUM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Resources related to the Food and Drug Administration

LobbyistCovered position, as disclosed
MARY MOODY JOHNSON —
SARA LOVE RAWLINGS —
JORDAN TENENBAUM —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.